CIGNA Co. (NYSE:CI) Director Jane E. Md Henney sold 400 shares of the firm’s stock in a transaction that occurred on Friday, January 12th. The stock was sold at an average price of $212.96, for a total transaction of $85,184.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
CIGNA Co. (CI) opened at $219.66 on Friday. The company has a quick ratio of 0.39, a current ratio of 0.39 and a debt-to-equity ratio of 0.37. The firm has a market capitalization of $54,329.69, a price-to-earnings ratio of 24.06, a price-to-earnings-growth ratio of 1.47 and a beta of 0.51. CIGNA Co. has a fifty-two week low of $133.52 and a fifty-two week high of $221.13.
CIGNA (NYSE:CI) last announced its quarterly earnings data on Thursday, November 2nd. The health services provider reported $2.83 earnings per share for the quarter, beating analysts’ consensus estimates of $2.36 by $0.47. The company had revenue of $10.38 billion for the quarter, compared to analyst estimates of $10.17 billion. CIGNA had a return on equity of 18.85% and a net margin of 5.74%. The firm’s revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.94 EPS. equities research analysts forecast that CIGNA Co. will post 10.34 earnings per share for the current fiscal year.
Hedge funds have recently made changes to their positions in the business. Saratoga Research & Investment Management purchased a new position in shares of CIGNA during the 3rd quarter worth $112,000. Capstone Investment Advisors Netherlands B.V. purchased a new position in shares of CIGNA during the 2nd quarter worth $106,000. Horan Capital Advisors LLC. purchased a new position in shares of CIGNA during the 3rd quarter worth $123,000. Grove Bank & Trust raised its holdings in shares of CIGNA by 171.9% during the 3rd quarter. Grove Bank & Trust now owns 976 shares of the health services provider’s stock worth $182,000 after acquiring an additional 617 shares during the period. Finally, Steward Partners Investment Advisory LLC purchased a new position in shares of CIGNA during the 3rd quarter worth $185,000. Institutional investors own 87.75% of the company’s stock.
A number of equities research analysts have recently commented on CI shares. Jefferies Group raised their price objective on shares of CIGNA from $221.00 to $231.00 and gave the stock a “buy” rating in a research note on Friday, November 3rd. Zacks Investment Research lowered CIGNA from a “buy” rating to a “hold” rating in a research report on Friday, November 10th. Citigroup increased their target price on CIGNA from $198.00 to $231.00 and gave the company a “buy” rating in a research report on Friday, November 3rd. ValuEngine upgraded CIGNA from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Finally, BMO Capital Markets assumed coverage on CIGNA in a research report on Monday, October 16th. They set a “market perform” rating and a $210.00 target price on the stock. Three research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $205.18.
TRADEMARK VIOLATION NOTICE: This story was originally published by TrueBlueTribune and is owned by of TrueBlueTribune. If you are viewing this story on another website, it was illegally copied and republished in violation of United States & international trademark & copyright law. The original version of this story can be viewed at https://www.truebluetribune.com/2018/01/19/jane-e-md-henney-sells-400-shares-of-cigna-co-ci-stock.html.
CIGNA Company Profile
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for CIGNA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CIGNA and related companies with MarketBeat.com's FREE daily email newsletter.